Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
163 hedge funds and large institutions have $1.82B invested in Amedisys in 2017 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 77 increasing their positions, 39 reducing their positions, and 29 closing their positions.
371% more call options, than puts
Call options by funds: $8.54M | Put options by funds: $1.81M
97% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 39
2% less ownership
Funds ownership: 97.97% → 95.97% (-2%)
4% less funds holding
Funds holding: 169 → 163 (-6)
12% less capital invested
Capital invested by funds: $2.08B → $1.82B (-$257M)
14% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 29
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
+$25.9M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$25.1M |
| 3 |
Millennium Management
New York
|
+$24.2M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$21.3M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
-$91.9M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$51.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$30.9M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$22M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$14.5M |
AMED Hedge Fund Activity: Q3 2017 in Review
163 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q3 2017, worth a combined $1.82B — down 12% from $2.08B a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of AMED and 25 opened new positions — a net loss of 4 holders — while 39 trimmed existing stakes and 77 added.
The largest buyer was American Century Companies, adding an estimated $25.9M. The largest seller was William Blair Investment Management, exiting entirely with an estimated $91.9M sold.
- 163 institutional investors held Amedisys (AMED) as of Q3 2017, down from 169 in Q2 2017.
- Funds reported $1.82B of Amedisys stock for Q3 2017, down 12% quarter-over-quarter.
- 25 funds opened new Amedisys positions in Q3 2017 and 29 closed out, a net change of -4 holders.
- The largest Amedisys buyer in Q3 2017 was American Century Companies, an estimated $25.9M added.
- The largest Amedisys seller in Q3 2017 was William Blair Investment Management, an estimated $91.9M sold.
Based on aggregated 13F filings for Q3 2017.